Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02750813 · ClinicalTrials.gov registry record · NA
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®
A NA study, sponsored by Alcon, a Novartis Company.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
NCT02750813: Completed NA study, sponsored by Alcon, a Novartis Company.
NCT02750813 is a NA study that has completed, run by Alcon, a Novartis Company. The registered enrollment target is 252 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02750813, a NA study, has completed, sponsored by Alcon, a Novartis Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the lens fit characteristics, specifically lens centration, of ACUVUE® OASYS® 1-DAY (AO1D) contact lenses and DAILIES TOTAL1® (DT1) contact lenses.
Primary Outcome
Lens centration, was assessed by the investigator for each eye individually and rated on a 5-point scale: 0=centered/optimal, 1=slight decentration, 2=mild decentration, 3=moderate decentration, 4=severe decentration. The combined percentage of lenses assessed as "centered" or "slight decentration" is reported. Lenses from both eyes contributed to the percentage.
Interventions
- DEVICE Delefilcon A contact lenses
- DEVICE Senofilcon A contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2016-04-27 |
| Est. Completion | 2016-08-17 |
| Phase | NA |
What the finished NCT02750813 record still lists
NCT02750813 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Delefilcon A contact lenses is the first listed.
NCT02750813 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02750813 about?
NCT02750813 is a clinical study titled "ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®". The purpose of this study is to compare the lens fit characteristics, specifically lens centration, of ACUVUE® OASYS® 1-DAY (AO1D) contact lenses and DAILIES TOTAL1® (DT1) contact lenses.
What is the current status of trial NCT02750813?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2016-04-27. Estimated completion is 2016-08-17.
What interventions are being tested in trial NCT02750813?
The interventions under investigation include: Delefilcon A contact lenses (DEVICE), Senofilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT02750813?
This trial is sponsored by Alcon, a Novartis Company, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02750813's enrollment target sits among peer trials
252 407th of 2000 higher than 1,591 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI